Literature DB >> 11297766

Genetic heterogeneity and alterations in chromosome 9 loci in a localized region of a functional pituitary adenoma.

G Jotwani1, A Misra, P Chattopadhyay, C Sarkar, A K Mahapatra, S Sinha.   

Abstract

The molecular alterations reported in pituitary adenomas include mutations at the G(s)alpha in somatotrophinomas, and hypermethylation of the p16 tumor suppressor gene. There are, however, no reports of genomic instability or intratumor genetic heterogeneity in pituitary adenomas. We have studied the microsatellite loci on the short arm of chromosome 9 (9p) and the DNA fingerprinting pattern, of adjacent compartments, about 2 mm across, in a functional chromophobe pituitary adenoma secreting growth hormone and prolactin. The microsatellite loci were studied by PCR amplification using locus specific primers, while the DNA fingerprinting pattern was studied by randomly amplified polymorphic DNA (RAPD) analysis. Normal leukocyte DNA was taken as control. Only one compartment (Ta) showed alterations in several of the microsatellite loci and in the RAPD pattern vis a vis corresponding normal DNA and also the other two compartments of the tumor. This provides evidence for the localized nature of genomic instability in this tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297766     DOI: 10.1016/s0165-4608(00)00356-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis.

Authors:  Anjan Misra; Parthaprasad Chattopadhyay; Kunzang Chosdol; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  BMC Cancer       Date:  2007-10-09       Impact factor: 4.430

2.  Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors.

Authors:  Kunzang Chosdol; Anjan Misra; Sachin Puri; Tapasya Srivastava; Parthaprasad Chattopadhyay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  BMC Cancer       Date:  2009-01-07       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.